83 related articles for article (PubMed ID: 35338146)
21. Role of chromosomal aberrations in clonal diversity and progression of acute myeloid leukemia.
Bochtler T; Fröhling S; Krämer A
Leukemia; 2015 Jun; 29(6):1243-52. PubMed ID: 25673237
[TBL] [Abstract][Full Text] [Related]
22. Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer?
Grove CS; Vassiliou GS
Dis Model Mech; 2014 Aug; 7(8):941-51. PubMed ID: 25056697
[TBL] [Abstract][Full Text] [Related]
23. Comparison of clonal architecture between primary and immunodeficient mouse-engrafted acute myeloid leukemia cells.
Kawashima N; Ishikawa Y; Kim JH; Ushijima Y; Akashi A; Yamaguchi Y; Hattori H; Nakashima M; Ikeno S; Kihara R; Nishiyama T; Morishita T; Watamoto K; Ozawa Y; Kitamura K; Kiyoi H
Nat Commun; 2022 Mar; 13(1):1624. PubMed ID: 35338146
[TBL] [Abstract][Full Text] [Related]
24. Clonal architecture of secondary acute myeloid leukemia.
Walter MJ; Shen D; Ding L; Shao J; Koboldt DC; Chen K; Larson DE; McLellan MD; Dooling D; Abbott R; Fulton R; Magrini V; Schmidt H; Kalicki-Veizer J; O'Laughlin M; Fan X; Grillot M; Witowski S; Heath S; Frater JL; Eades W; Tomasson M; Westervelt P; DiPersio JF; Link DC; Mardis ER; Ley TJ; Wilson RK; Graubert TA
N Engl J Med; 2012 Mar; 366(12):1090-8. PubMed ID: 22417201
[TBL] [Abstract][Full Text] [Related]
25. Pursuing dynamics of minimal residual leukemic subclones in relapsed and refractory acute myeloid leukemia during conventional therapy.
Kim D; Kim S; Song H; Gwak D; Min S; Byun JM; Koh Y; Hong J; Yoon SS; Yun H; Shin DY
Cancer Med; 2024 Apr; 13(7):e7182. PubMed ID: 38591109
[TBL] [Abstract][Full Text] [Related]
26. An advanced preclinical mouse model for acute myeloid leukemia using patients' cells of various genetic subgroups and in vivo bioluminescence imaging.
Vick B; Rothenberg M; Sandhöfer N; Carlet M; Finkenzeller C; Krupka C; Grunert M; Trumpp A; Corbacioglu S; Ebinger M; André MC; Hiddemann W; Schneider S; Subklewe M; Metzeler KH; Spiekermann K; Jeremias I
PLoS One; 2015; 10(3):e0120925. PubMed ID: 25793878
[TBL] [Abstract][Full Text] [Related]
27. Patient-derived xenotransplants can recapitulate the genetic driver landscape of acute leukemias.
Wang K; Sanchez-Martin M; Wang X; Knapp KM; Koche R; Vu L; Nahas MK; He J; Hadler M; Stein EM; Tallman MS; Donahue AL; Frampton GM; Lipson D; Roels S; Stephens PJ; Sanford EM; Brennan T; Otto GA; Yelensky R; Miller VA; Kharas MG; Levine RL; Ferrando A; Armstrong SA; Krivtsov AV
Leukemia; 2017 Jan; 31(1):151-158. PubMed ID: 27363283
[TBL] [Abstract][Full Text] [Related]
28. Engraftment characterization of risk-stratified AML in NSGS mice.
Díaz de la Guardia R; Velasco-Hernandez T; Gutiérrez-Agüera F; Roca-Ho H; Molina O; Nombela-Arrieta C; Bataller A; Fuster JL; Anguita E; Vives S; Zamora L; Nomdedeu J; Gómez-Casares MT; Ramírez-Orellana M; Lapillonne H; Ramos-Mejia V; Rodríguez-Manzaneque JC; Bueno C; Lopez-Millan B; Menéndez P
Blood Adv; 2021 Dec; 5(23):4842-4854. PubMed ID: 34470043
[TBL] [Abstract][Full Text] [Related]
29. Clonal competition within complex evolutionary hierarchies shapes AML over time.
Sandén C; Lilljebjörn H; Orsmark Pietras C; Henningsson R; Saba KH; Landberg N; Thorsson H; von Palffy S; Peña-Martinez P; Högberg C; Rissler M; Gisselsson D; Lazarevic V; Juliusson G; Ågerstam H; Fioretos T
Nat Commun; 2020 Feb; 11(1):579. PubMed ID: 32024830
[TBL] [Abstract][Full Text] [Related]
30. Prospective evaluation of prognostic impact of KIT mutations on acute myeloid leukemia with RUNX1-RUNX1T1 and CBFB-MYH11.
Ishikawa Y; Kawashima N; Atsuta Y; Sugiura I; Sawa M; Dobashi N; Yokoyama H; Doki N; Tomita A; Kiguchi T; Koh S; Kanamori H; Iriyama N; Kohno A; Moriuchi Y; Asada N; Hirano D; Togitani K; Sakura T; Hagihara M; Tomikawa T; Yokoyama Y; Asou N; Ohtake S; Matsumura I; Miyazaki Y; Naoe T; Kiyoi H
Blood Adv; 2020 Jan; 4(1):66-75. PubMed ID: 31899799
[TBL] [Abstract][Full Text] [Related]
31. Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia.
McMahon CM; Ferng T; Canaani J; Wang ES; Morrissette JJD; Eastburn DJ; Pellegrino M; Durruthy-Durruthy R; Watt CD; Asthana S; Lasater EA; DeFilippis R; Peretz CAC; McGary LHF; Deihimi S; Logan AC; Luger SM; Shah NP; Carroll M; Smith CC; Perl AE
Cancer Discov; 2019 Aug; 9(8):1050-1063. PubMed ID: 31088841
[TBL] [Abstract][Full Text] [Related]
32. Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation.
Toffalori C; Zito L; Gambacorta V; Riba M; Oliveira G; Bucci G; Barcella M; Spinelli O; Greco R; Crucitti L; Cieri N; Noviello M; Manfredi F; Montaldo E; Ostuni R; Naldini MM; Gentner B; Waterhouse M; Zeiser R; Finke J; Hanoun M; Beelen DW; Gojo I; Luznik L; Onozawa M; Teshima T; Devillier R; Blaise D; Halkes CJM; Griffioen M; Carrabba MG; Bernardi M; Peccatori J; Barlassina C; Stupka E; Lazarevic D; Tonon G; Rambaldi A; Cittaro D; Bonini C; Fleischhauer K; Ciceri F; Vago L
Nat Med; 2019 Apr; 25(4):603-611. PubMed ID: 30911134
[TBL] [Abstract][Full Text] [Related]
33. Murine Models of Acute Myeloid Leukaemia.
Almosailleakh M; Schwaller J
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30669675
[TBL] [Abstract][Full Text] [Related]
34. The influence of mutational status and biological characteristics of acute myeloid leukemia on xenotransplantation outcomes in NOD SCID gamma mice.
Culen M; Kosarova Z; Jeziskova I; Folta A; Chovancova J; Loja T; Tom N; Bystry V; Janeckova V; Dvorakova D; Mayer J; Racil Z
J Cancer Res Clin Oncol; 2018 Jul; 144(7):1239-1251. PubMed ID: 29721667
[TBL] [Abstract][Full Text] [Related]
35. Acute myeloid leukemia xenograft success prediction: Saving time.
Griessinger E; Vargaftig J; Horswell S; Taussig DC; Gribben J; Bonnet D
Exp Hematol; 2018 Mar; 59():66-71.e4. PubMed ID: 29253573
[TBL] [Abstract][Full Text] [Related]
36. Patient-derived xenografts undergo mouse-specific tumor evolution.
Ben-David U; Ha G; Tseng YY; Greenwald NF; Oh C; Shih J; McFarland JM; Wong B; Boehm JS; Beroukhim R; Golub TR
Nat Genet; 2017 Nov; 49(11):1567-1575. PubMed ID: 28991255
[TBL] [Abstract][Full Text] [Related]
37. Clonal evolution in leukemia.
Ferrando AA; López-Otín C
Nat Med; 2017 Oct; 23(10):1135-1145. PubMed ID: 28985206
[TBL] [Abstract][Full Text] [Related]
38. Tracing the origins of relapse in acute myeloid leukaemia to stem cells.
Shlush LI; Mitchell A; Heisler L; Abelson S; Ng SWK; Trotman-Grant A; Medeiros JJF; Rao-Bhatia A; Jaciw-Zurakowsky I; Marke R; McLeod JL; Doedens M; Bader G; Voisin V; Xu C; McPherson JD; Hudson TJ; Wang JCY; Minden MD; Dick JE
Nature; 2017 Jul; 547(7661):104-108. PubMed ID: 28658204
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
